by American Society for Microbiology
Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more. The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.
Language
🇺🇲
Publishing Since
8/4/2020
Email Addresses
1 available
Phone Numbers
0 available
April 4, 2025
<p>Picture this, you wake up one morning with nausea, body aches, abdominal pain, and despite sleeping all night, you are exhausted. You then find yourself running to the restroom with watery and somewhat explosive diarrhea. You think to yourself – what could this be? Well, if the year was 2023, in the summer and you happen to live in Texas, chances were somewhat high that you had probably had cyclosporiasis. And today, we are going to talk about this particular parasite and focus in on what our options are for detecting it given that it is not routinely picked up on O&P exams. And while there are molecular panels out there that include Cyclospora as a target, as our speakers will share, there is an easier and cheaper approach we can consider to quickly ID this pathogen.</p> <h3><strong>Guests:</strong></h3> <ul> <li><a href= "https://www.publichealthontario.ca/en/About/Research/Our-Researchers/Angela-Ma" target="_blank" rel="noopener">Dr. Angela Ma.</a> Public Health Ontario and Assistant Professor at the University of Toronto</li> <li>Dr. Marc Couturier. Drector of the clinical microbiology lab at NorDx lab at MaineHealth in Scarborough, Maine</li> </ul> <h3><strong>Links:</strong></h3> <ul> <li>Shedding new light on Cyclospora: <a href= "https://journals.asm.org/doi/10.1128/jcm.01084-24" target="_blank" rel="noopener">how the use of ultraviolet fluorescence microscopy can improve diagnosis of cyclosporiasis</a></li> <li><a href="https://bit.ly/asmmembership" target="_blank" rel= "noopener">Join ASM</a> for up to 50% off the publication fees when you publish in JCM or any of the ASM journals.</li> <li>Attend <a href="https://bit.ly/asmmicrobe" target="_blank" rel= "noopener">ASM Microbe</a></li> </ul> <p>This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at <a href= "https://jcm.asm.org" target="_blank" rel= "noopener">https://jcm.asm.org</a> and on <a href= "https://twitter.com/JClinMicro" target="_blank" rel= "noopener">https://twitter.com/JClinMicro</a>.<br /> <br /> Visit <a href="https://journals.asm.org/journal/jcm" target= "_blank" rel="noopener">journals.asm.org/journal/jcm</a> to read articles and/or submit a manuscript.</p> <p>Follow <a href="https://twitter.com/jclinmicro" target="_blank" rel="noopener">JCM on Twitter/𝕏 via @JClinMicro</a></p>
February 14, 2025
<p>The past year in Clinical Microbiology, as seen through the lens of the Journal of Clinical Microbiology. Four JCM editors have each selected a paper they consider to be among the “best” we published in 2024. Of course there are no objective criteria for what makes a paper the “best.” So, by “best,” we mean “a paper that I find exciting.”</p> <p>View this episode: https://www.youtube.com/watch?v=fK9ZqZUrDiY</p> <h3><strong>Guests:</strong></h3> <ul> <li><a href="https://asm.org/biographies/patricia-simner" target= "_blank" rel="noopener">Patricia Simner, Ph.D., D(ABMM)</a>, Johns Hopkins University School of Medicine</li> <li><a href= "http://Romney%20Humphries,%20Ph.D.,%20D(ABMM),%20M(ASCP)" target= "_blank" rel="noopener">Romney Humphries, Ph.D., D(ABMM), M(ASCP</a>), Vanderbilt University Medical Center</li> </ul> <h3><strong>Links:</strong></h3> <ul> <li>Wood RC, Luabeya AK, Dragovich RB, Olson AM, Lochner KA, Weigel KM, Codsi R, Mulenga H, de Vos M, Kohli M, Penn-Nicholson A, Hatherill M, Cangelosi GA. 2024. <a href= "https://doi.org/10.1128/jcm.00019-24" target="_blank" rel= "noopener">Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB Ultima.</a> J Clin Microbiol 62:e00019-24.</li> <li>Rodino KG, Luethy PM, Abbott AN, Bender JM, Eberly AR, Gitman M, Leber A, Dien Bard J, . 2024. <a href= "http://https//doi.org/10.1128/jcm.00359-24" target="_blank" rel= "noopener">Defining the value of medical microbiology consultation</a>. J Clin Microbiol 62:e00359-24.</li> <li>Giske CG, Bressan M, Fiechter F, Hinic V, Mancini S, Nolte O, Egli A. 2024. GPT-4-based AI agents—the new expert system for detection of antimicrobial resistance mechanisms?. J Clin Microbiol 62:e00689-24.</li> <li>Bloomfield M, van der Werff K, Todd S, Bocacao M, Reed H, Balm M, Blackmore T. 2024. <a href= "http://https//doi.org/10.1128/jcm.00342-24" target="_blank" rel= "noopener">An exception-reporting approach for wound swab culture: effect on post-report antibiotic initiation</a>. J Clin Microbiol 62:e00342-24.</li> <li><a href="https://bit.ly/asmmembership" target="_blank" rel= "noopener">Join ASM</a> for up to 50% off the publication fees when you publish in JCM or any of the ASM journals.</li> <li>Attend <a href="https://bit.ly/asmmicrobe" target="_blank" rel= "noopener">ASM Microbe</a></li> </ul> <p>This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at <a href= "https://jcm.asm.org" target="_blank" rel= "noopener">https://jcm.asm.org</a> and on <a href= "https://twitter.com/JClinMicro" target="_blank" rel= "noopener">https://twitter.com/JClinMicro</a>.<br /> <br /> Visit <a href="https://journals.asm.org/journal/jcm" target= "_blank" rel="noopener">journals.asm.org/journal/jcm</a> to read articles and/or submit a manuscript.</p> <p>Follow <a href="https://twitter.com/jclinmicro" target="_blank" rel="noopener">JCM on Twitter/𝕏 via @JClinMicro</a></p>
January 25, 2025
<p>2024 was a very active year on research in antimicrobial resistance, highlighted by an impactful and high level political declaration to combat antimicrobial resistance by the United Nations. In this episode, trainees from NIH-funded training program (T32) on antimicrobial resistance will help me discuss the most relevant research on the field in the year 2024. Welcome to editors in conversation!</p> <h2><strong>Topics discussed:</strong></h2> <ul> <li>The best papers of 2024 in gram-positive, gram-negative, mycobacterial and parasite resistance</li> </ul> <h2><strong>Guests:</strong></h2> <ul> <li>Nathalie Chen: University of Pittsburgh, Pittsburgh, PA</li> <li>Alex Kang: Houston Methodist Research Institute, Houston, TX</li> <li>Nathan Rabbe: University of Pittsburgh, Pittsburgh, PA</li> <li>Taylor Blackburn: Emory University, Atlanta, GA</li> <li>Jacon McPherson: University of Houston, Houston, TX.</li> <li>Harrison Lee, MD: Associate Chief of Epidemiology and Microbial Genomics, Professor of Medicine and Epidemiology, Director, Center for Genomic Epidemiology, Director, T32 AMR, U of Pittsburgh</li> <li>William Shafer, PhD: Professor, Department of Microbiology and Immunology, Emory University School of Medicine, Co-Director, Emory Antibiotic Resistance Center. Director T32 AMR, Emory University</li> </ul> <p>This episode is brought to you by the <a href= "http://asm.org/aac">Antimicrobial Agents and Chemotherapy Journal</a>. </p> <p>Visit <a href="https://aac.asm.org" target="_blank" rel= "noopener">asm.org/</a><a href="https://aac.asm.org" target= "_blank" rel="noopener">aa</a><a href="http://asm.org/aac">c</a> to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit <a href= "https://asm.org/membership" target="_blank" rel= "noopener">asm.org/</a><a href= "https://asm.org/membership">joinasm</a> to sign up.</p>
Society of Infectious Diseases Pharmacists
Vincent Racaniello
Sara Dong
Vincent Racaniello
Vincent Racaniello
Vincent Racaniello
NEJM Group
JAMA Network
Vincent Racaniello
NEJM Group
JAMA Network
The Clinical Problem Solvers
American Academy of Neurology
American College of Physicians
The Curious Clinicians
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.